167 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
Exhibit 99.4
Chiesi Farmaceutici S.p.A. Completes Acquisition of
Amryt Pharma Plc
Acquisition positions Chiesi to expand patient access … and acts as a force for good, for society and the planet. The goal of the Global Rare Diseases unit is to ensure equal access so as many people as possible
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
in the Netherlands suffering from generalized lipodystrophy the opportunity to access Myalepta®. This news represents further progress in our efforts … of it with access to any additional relevant information that may arise in connection with it. Such forward-looking statements reflect the Company’s
6-K
EX-99.2
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
in this announcement or to provide the recipient of it with access to any additional relevant information that may arise in connection with it. Such forward-looking
6-K
EX-99.3
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
from November 3, 2022 - November 10, 2022. Access details for the playback facility are as follows: Dial +39 02 802 0987, then press 700723# and 723 … to update or keep current the information contained in this announcement or to provide the recipient of it with access to any additional relevant
6-K
EX-99.4
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
the recipient of it with access to any additional relevant information that may arise in connection with it. Such forward-looking statements reflect
6-K
EX-99.5
6g3vr2 mhg4r
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.7
r360zzw
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.6
xh19 ceizm3oz33zf
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
78y3 gp8icv38
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.4
wr87sic74zkwrpdxw4c
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.2
q2345 z3ha4
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
zuu7tqw
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.5
0j1oo
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.1
4fqae90 2cx
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.4
8t3mef2v9z09r91
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.3
2lnqezb
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.2
z43 2pgvd6f7v
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.1
ueg2akz0ecblw64e
24 Jun 22
Filsuvez® recently approved by the European Commission for the treatment of EB
7:18am
6-K
EX-99.1
o84ry
23 Jun 22
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB
7:26am
6-K
EX-99.2
hl1b4 si3m2wbly
1 Jun 22
Current report (foreign)
6:05am